1h Free Analyst Time
Global Multiplexed Diagnostics Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the global multiplexed diagnostics market and it is poised to grow by USD 9.35 bn during 2020-2024, progressing at a CAGR of 15% during the forecast period. This report on the global multiplexed diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by prevalence of chronic and infectious diseases. In addition, technological advancements is anticipated to boost the growth of the global multiplexed diagnostics market as well.
Market Segmentation
The global multiplexed diagnostics market is segmented as below:
End-User:
- Pharmaceutical and Biotechnology Companies
- Healthcare Centers
- Academic Institutes and Cros
Geographic segmentation:
- APAC
- Europe
- MEA
- North America
- South America
Key Trends for global multiplexed diagnostics market growth
This study identifies technological advancements as the prime reasons driving the global multiplexed diagnostics market growth during the next few years.
Prominent vendors in global multiplexed diagnostics market
The publisher provides a detailed analysis of around 25 vendors operating in the global multiplexed diagnostics market, including some of the vendors such as Agilent Technologies Inc., Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, QIAGEN NV, F. Hoffmann-La Roche Ltd., Siemens AG and Thermo Fisher Scientific Inc..
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global multiplexed diagnostics market: Agilent Technologies Inc., Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, QIAGEN NV, F. Hoffmann-La Roche Ltd., Siemens AG and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements."
According to the report, one of the major drivers for this market is the prevalence of chronic and infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Becton, Dickinson and Co.
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Merck KGaA
- QIAGEN NV
- F. Hoffmann-La Roche Ltd.
- Siemens AG
- Thermo Fisher Scientific Inc.
